InvestorsHub Logo
Replies to #76343 on Biotech Values
icon url

masterlongevity

04/21/09 4:40 PM

#76349 RE: DewDiligence #76343


Avastin was priced at about 40% of what the model suggested it should've been.

Lenny Saltz is no economist and his argument does pts more harm than good. he should stick to treating pts
icon url

jbog

04/21/09 5:13 PM

#76350 RE: DewDiligence #76343

Dew,

In my view Avastin, Erby et al are all way too expensive, and they simply don't provide the benefit versus their costs.

Would I use these drugs? Absolutely!

But as an country, we simply cannot afford them. Gosh, how would we actually price a drug that cured cancer.